- BrosMed Medical closes Series C round led by Hillhouse Capital
- Wedge NC Scoring Balloon Dilatation Catheter received CE mark
- Alveo HP Balloon(Ø0.75mm) Dilatation Catheter received CE mark
- Tri-Wedge PTA Scoring Balloon Dilatation Catheter received CE mark
- Interventional Accessories 2020 received CE mark
- Annual sales exceeded 100 million RMB
- Shenzhen Subsidiary was established
- BrosMed won the Leading Enterprise of the TOP 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area Award 2020.
- Brun Medical Co., Ltd. was established.
- BrosMed won the Leading Enterprise of the TOP 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area Award 2019.
- BrosMed PTCA/PTA products won the “High-tech Product of Guangdong Province”
- BrosMed Medical won the “High-tech Enterprise Certificate”
- BrosMed Medical won the Champion in the 2018 Dongguan Innovation and Entrepreneurship Competition
- Artimes™ and Apollo™ PTCA Balloon Dilatation Catheter received PMDA approval, Officially entered Japan market.
- BrosMed Announces Strategic Agreement with Cardinal Health
- Wedge™ Semi-complaint Scoring PTCA received CE mark
- India Subsidiary was established
- Conger™ Hydrophilic Guide Wire received CE mark
- BrosMed PTA products received CE mark
- LEED International Co., Limited was established in HK
- Apollo™ PTCA Balloon Dilatation Catheter received CE mark
- BrosMed Medical B.V. was established in the Netherlands
- BrosMed received the certificates of ISO13485 & ISO 9001
- Artimes™ Balloon Dilatation Catheter received CE mark
- Brosmed Medical won Special Award in 2013 Dongguan Innovation and Entrepreneurship Competition
- Headquarters Founded in Songshan Lake Hi-Tech Industrial Development Zone, Dongguan